申请人:Takeda Pharmaceutical Company Limited
公开号:EP1911738A1
公开(公告)日:2008-04-16
The present invention provides a compound represented by the formula:
wherein each symbol is as defined in the specification.
Since the compound of the present invention has superior hypoglycemic action and superior hypolipidemic action, it is useful as an agent for the prophylaxis or treatment of diabetes, hyperlipidemia, impaired glucose tolerance and the like.
本发明提供了一种由式表示的化合物:
其中各符号如说明书中所定义。
由于本发明的化合物具有优异的降血糖作用和降血脂作用,因此可作为预防或治疗糖尿病、高脂血症、糖耐量受损等疾病的药物。